WKN: | 936853 |
ISIN: | US28176E1082 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Medizintechnik |
Weshalb die Edwards Lifesciences-Aktie
ein AAA-Rating hat,
erfahren Sie im Performance-Check
vom 19. Oktober 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2014 | 7,97 | 17,66 | 121,61% |
2 | 2010 | 5,06 | 10,43 | 106,19% |
3 | 2009 | 3,12 | 5,06 | 62,31% |
4 | 2019 | 43,37 | 70,17 | 61,80% |
5 | 2021 | 73,50 | 115,55 | 57,21% |
6 | 2015 | 17,66 | 24,38 | 38,10% |
7 | 2018 | 31,60 | 43,37 | 37,24% |
8 | 2012 | 9,13 | 11,40 | 24,89% |
9 | 2004 | 1,98 | 2,46 | 24,47% |
10 | 2016 | 24,38 | 29,57 | 21,27% |
11 | 2008 | 2,62 | 3,12 | 18,80% |
12 | 2005 | 2,46 | 2,92 | 18,61% |
13 | 2017 | 29,57 | 31,60 | 6,87% |
14 | 2020 | 70,17 | 73,50 | 4,75% |
15 | 2024 | 69,00 | 72,02 | 4,38% |
16 | 2006 | 2,92 | 3,00 | 2,80% |
17 | 2023 | 70,10 | 69,00 | -1,57% |
18 | 2003 | 2,03 | 1,98 | -2,47% |
19 | 2007 | 3,00 | 2,62 | -12,45% |
20 | 2011 | 10,43 | 9,13 | -12,51% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2022 | 115,55 | 70,10 | -39,33% |
2 | 2013 | 11,40 | 7,97 | -30,11% |
3 | 2002 | 2,58 | 2,03 | -21,61% |
4 | 2025 | 72,02 | 62,13 | -13,73% |
5 | 2011 | 10,43 | 9,13 | -12,51% |
6 | 2007 | 3,00 | 2,62 | -12,45% |
7 | 2003 | 2,03 | 1,98 | -2,47% |
8 | 2023 | 70,10 | 69,00 | -1,57% |
9 | 2006 | 2,92 | 3,00 | 2,80% |
10 | 2024 | 69,00 | 72,02 | 4,38% |
11 | 2020 | 70,17 | 73,50 | 4,75% |
12 | 2017 | 29,57 | 31,60 | 6,87% |
13 | 2005 | 2,46 | 2,92 | 18,61% |
14 | 2008 | 2,62 | 3,12 | 18,80% |
15 | 2016 | 24,38 | 29,57 | 21,27% |
16 | 2004 | 1,98 | 2,46 | 24,47% |
17 | 2012 | 9,13 | 11,40 | 24,89% |
18 | 2018 | 31,60 | 43,37 | 37,24% |
19 | 2015 | 17,66 | 24,38 | 38,10% |
20 | 2021 | 73,50 | 115,55 | 57,21% |